{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:35:51Z","timestamp":1794609351718,"version":"4.9.1"},"reference-count":74,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:00:00Z","timestamp":1721520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Epilepsy is associated with substantial neuropsychiatric impairments that persist long after the onset of the condition, significantly impacting quality of life. The goal of this review was to uncover how the pathological consequences of epilepsy, such as excessive glutamate release and a disrupted blood\u2013brain barrier (BBB), contribute to the emergence of neuropsychiatric disorders. We hypothesize that epilepsy induces a dysfunctional BBB through hyperexcitation, which then further amplifies post-ictal glutamate levels and, thus, triggers neurodegenerative and neuropsychiatric processes. This review identifies the determinants of glutamate concentration levels in the brain and explores potential therapeutic interventions that restore BBB integrity. Our focus on therapeutic BBB restoration is guided by the premise that it may improve glutamate regulation, consequently mitigating the neurotoxicity that contributes to the onset of neuropsychiatric symptoms.<\/jats:p>","DOI":"10.3390\/cells13141228","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T08:24:59Z","timestamp":1721636699000},"page":"1228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Role of Glutamate and Blood\u2013Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3120-5709","authenticated-orcid":false,"given":"Benjamin F.","family":"Gruenbaum","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Schonwald","sequence":"additional","affiliation":[{"name":"New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-1643","authenticated-orcid":false,"given":"Matthew","family":"Boyko","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zlotnik","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"St\u00f6ber, T.M., Batulin, D., Triesch, J., Narayanan, R., and Jedlicka, P. (2023). Degeneracy in epilepsy: Multiple routes to hyperexcitable brain circuits and their repair. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-04823-0"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jocn.2008.08.026","article-title":"Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy\u2013Part 1","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/epi.13766","article-title":"Psychiatric and behavioral comorbidities in epilepsy: A critical reappraisal","volume":"58","author":"Berg","year":"2017","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1528-1167.2010.02907.x","article-title":"Depression and epilepsy: A bidirectional relation?","volume":"52","author":"Kanner","year":"2011","journal-title":"Epilepsia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3988\/jcn.2014.10.3.175","article-title":"Depression and anxiety in people with epilepsy","volume":"10","author":"Kwon","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/epi.16862","article-title":"Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality","volume":"62","author":"Gruenbaum","year":"2021","journal-title":"Epilepsia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1474-4422(04)00906-8","article-title":"Chronic epilepsy and cognition","volume":"3","author":"Elger","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/epd.2015.0739","article-title":"Cognitive impairment in epilepsy: The role of network abnormalities","volume":"17","author":"Holmes","year":"2015","journal-title":"Epileptic. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.seizure.2007.09.001","article-title":"Stigma, seizure frequency and quality of life: The impact of epilepsy in late adulthood","volume":"17","author":"McLaughlin","year":"2008","journal-title":"Seizure"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: Experimental approaches and translational research","volume":"62","author":"Brandt","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107869","DOI":"10.1016\/j.yebeh.2021.107869","article-title":"Behavioral comorbidities of epilepsy and neuroinflammation: Evidence from experimental and clinical studies","volume":"117","author":"Suleymanova","year":"2021","journal-title":"Epilepsy Behav."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6564585","DOI":"10.1155\/2021\/6564585","article-title":"Blood-brain barrier overview: Structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2020.03.018","article-title":"Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules","volume":"160","author":"Harilal","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: Pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcdb.2014.10.003","article-title":"Blood\u2013brain barrier dysfunction, seizures and epilepsy","volume":"38","author":"Aronica","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic Mechanisms Associated with Seizures and Epilepsy","volume":"5","author":"White","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1523\/JNEUROSCI.17-21-08588.1997","article-title":"Status Epilepticus-Induced Alterations in Metabotropic Glutamate Receptor Expression in Young and Adult Rats","volume":"17","author":"Eleonora","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","article-title":"Brain concentrations of glutamate and GABA in human epilepsy: A review","volume":"91","author":"Sarlo","year":"2021","journal-title":"Seizure"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/epi.12285","article-title":"Trafficking of NMDA receptors during status epilepticus: Therapeutic implications","volume":"54","author":"Wasterlain","year":"2013","journal-title":"Epilepsia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.09.013","article-title":"Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives","volume":"203","author":"Dorandeu","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2012.07.046","article-title":"Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats","volume":"1474","author":"Loss","year":"2012","journal-title":"Brain Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/ebeh.2000.0030","article-title":"Depression in epilepsy: A common but often unrecognized comorbid malady","volume":"1","author":"Kanner","year":"2000","journal-title":"Epilepsy Behav."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nasir, M., Trujillo, D., Levine, J., Dwyer, J.B., Rupp, Z.W., and Bloch, M.H. (2020). Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.548505"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S1092852900010427","article-title":"The role of glutamate in anxiety and related disorders","volume":"10","author":"Cortese","year":"2005","journal-title":"CNS Spectr"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/wps.20701","article-title":"A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression","volume":"19","author":"Cuijpers","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","article-title":"Efficacy of treatments for anxiety disorders: A meta-analysis","volume":"30","author":"Bandelow","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gruenbaum, B.F., Zlotnik, A., Fleidervish, I., Frenkel, A., and Boyko, M. (2022). Glutamate Neurotoxicity and Destruction of the Blood-Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179628"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11920-007-0033-7","article-title":"Glutamate and anxiety disorders","volume":"9","author":"Amiel","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pal, M.M. (2021). Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders. Front. Hum. Neurosci., 15.","DOI":"10.3389\/fnhum.2021.722323"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","article-title":"Glutamate and anxiety","volume":"14","author":"Bergink","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zoicas, I., and Kornhuber, J. (2019). The Role of the N-Methyl-D-Aspartate Receptors in Social Behavior in Rodents. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225599"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.conb.2011.12.006","article-title":"Regulation of AMPA receptor trafficking and synaptic plasticity","volume":"22","author":"Anggono","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1167.2005.01021.x","article-title":"Plasticity, synaptic strength, and epilepsy: What can we learn from ultrastructural data?","volume":"46","author":"Leite","year":"2005","journal-title":"Epilepsia"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Turrigiano, G. (2012). Homeostatic synaptic plasticity: Local and global mechanisms for stabilizing neuronal function. Cold Spring Harb. Perspect. Biol., 4.","DOI":"10.1101\/cshperspect.a005736"},{"key":"ref_42","first-page":"196","article-title":"Blood\u2013brain barrier disruption following seizures","volume":"19","author":"Kiani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"106285","DOI":"10.1016\/j.yebeh.2019.04.038","article-title":"Blood\u2013brain barrier dysfunction in status epileptics: Mechanisms and role in epileptogenesis","volume":"101","author":"Swissa","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"L\u00f6scher, W., and Friedman, A. (2020). Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020591"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"867s","DOI":"10.3945\/ajcn.2009.27462BB","article-title":"The blood-brain barrier and glutamate","volume":"90","author":"Hawkins","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_46","unstructured":"Scharfman, H.E., and Buckmaster, P.S. (2014). When and How Do Seizures Kill Neurons, and Is Cell Death Relevant to Epileptogenesis?. Issues in Clinical Epileptology: A View from the Bench, Springer."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coph.2007.07.005","article-title":"Modulators of neuronal cell death in epilepsy","volume":"8","author":"Henshall","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/7854_2016_40","article-title":"Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications","volume":"31","author":"Haroon","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials","volume":"71","author":"Benros","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41380-023-02072-5","article-title":"Infections and neuropsychiatric disorders: New studies document pathways to prevention and treatment","volume":"28","author":"Yolken","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"102127","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: A systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1111\/bcp.15374","article-title":"Ketamine treatment for refractory anxiety: A systematic review","volume":"88","author":"Tully","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/npp.2013.61","article-title":"Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide\u2014A 3T-MRS study in healthy subjects","volume":"38","author":"Zwanzger","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0166-2236(00)01674-X","article-title":"ATP: An extracellular signaling molecule between neurons and glia","volume":"23","author":"Fields","year":"2000","journal-title":"Trends Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0896-6273(03)00717-7","article-title":"ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression","volume":"40","author":"Zhang","year":"2003","journal-title":"Neuron"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"175733","DOI":"10.1016\/j.ejphar.2023.175733","article-title":"Glutamate dehydrogenase: Potential therapeutic targets for neurodegenerative disease","volume":"950","author":"Pan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1248\/bpb.b21-00408","article-title":"Claudin-5: A pharmacological target to modify the permeability of the blood\u2013brain barrier","volume":"44","author":"Hashimoto","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: Gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Takata, F., Nakagawa, S., Matsumoto, J., and Dohgu, S. (2021). Blood-brain barrier dysfunction amplifies the development of neuroinflammation: Understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.661838"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/1742-2094-10-80","article-title":"Disruption of the blood\u2013brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels","volume":"10","author":"Li","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bronisz, E., Cudna, A., Wierzbicka, A., and Kurkowska-Jastrz\u0119bska, I. (2023). Blood-brain barrier-associated proteins are elevated in serum of epilepsy patients. Cells, 12.","DOI":"10.3390\/cells12030368"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/epi.16386","article-title":"SCN1A-related phenotypes: Epilepsy and beyond","volume":"60","author":"Scheffer","year":"2019","journal-title":"Epilepsia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/humu.20178","article-title":"SCN1A mutations and epilepsy","volume":"25","author":"Mulley","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12264-017-0182-6","article-title":"Functional investigation of a GRIN2A variant associated with rolandic epilepsy","volume":"34","author":"Xu","year":"2018","journal-title":"Neurosci. Bull."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejpn.2017.01.001","article-title":"Epilepsy in patients with GRIN2A alterations: Genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs","volume":"21","author":"Ensslen","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","article-title":"The SLC1 high-affinity glutamate and neutral amino acid transporter family","volume":"34","author":"Kanai","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00424-003-1146-4","article-title":"The glutamate\/neutral amino acid transporter family SLC1: Molecular, physiological and pharmacological aspects","volume":"447","author":"Kanai","year":"2004","journal-title":"Pfl\u00fcgers Arch."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2015.02.013","article-title":"TGF-\u03b21 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats","volume":"266","author":"Cai","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e2101090","DOI":"10.1002\/advs.202101090","article-title":"Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1227\/01.NEU.0000349931.61771.52","article-title":"Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats","volume":"65","author":"Li","year":"2009","journal-title":"Neurosurgery"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.omtn.2019.12.024","article-title":"MicroRNAs: Possible Regulatory Molecular Switch Controlling the BBB Microenvironment","volume":"19","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.23529","article-title":"Macrophages prevent hemorrhagic infarct transformation in murine stroke models","volume":"71","author":"Gliem","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"21","author":"Friedrich","year":"2012","journal-title":"Cell Transpl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2008.03.003","article-title":"Nimesulide as a promising neuroprotectant in brain ischemia: New experimental evidences","volume":"57","year":"2008","journal-title":"Pharmacol. Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/14\/1228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:20:38Z","timestamp":1760109638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/14\/1228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,21]]},"references-count":74,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["cells13141228"],"URL":"https:\/\/doi.org\/10.3390\/cells13141228","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,21]]}}}